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%K%p~s. w%re ~umor Lree~z b~,. z m~uj oeTore reinauction Tor .~ -~J mzns.; < p~s. naa arK with the R~)~r~, zKeaTment..lhe, pretr@azmenz was rw in * pzs. ano.vmL/~Lm/ zrv in z2z. ,tne Des• cn@nce !oqa salvage nave pzs. w~zn ~!~b~T kK, m<u or pro)ongeo rK o#.primary, zreazmenz ~r177 in,pzs, with a snorz inzervalT~gmP~ zo, progressTon zne cnance TOr salv@ge 1% pqorer.tz/1~), wnere~s ~n pz$.,with.progressign unoeu ingvction zqea!menz Do cnanc@ exls~S.WlZn any salva.~e cpemo~nerapy, anozner lmporzapz preoiczive Taczor is zne zype and aggressiveness of ~ne primary chemotherapy: 1/3 pts. treated with a ~fosfamide -out, not Cis~l@tinum,~#on~aining regimen (.IVB) haa a.bK w!~n %^b~pia~inum~w• containlnQ reinouczion, ana ~/~o pzs~ t~b%),could De saJvageo.wi% h Platinum/VP16 after pre~reatmenz.w~n wv~. in cqn~ras~ pts.. wno nave o?en prezrea~eo wlzn ~9re. aggressive ana acz~ve regimens zne co@rice #or. an e.TTeczive salvage treatmeD.z was .m#n#ma~: o~ly z/m pzs..afzer prior ~reazmen~with HVBI apa u~m p~s. after ~rior ~reazmen~ wi~n bisp~a~inum ultra nignaose/-VP16/Bl?omyci,nare,diseasefree. ~onclusio,ns: 18% o L the p#s. acniey~g a oisease Tree .Status wizn salvage cnemoznerapy ~#b%) +~-surgery.(3%)..P,ts, w~th ,relapse after primary bK or a longer laszlng, szaDle vK ana particularly p~s. ~retreatea wizn stanaara cnemotherapy with meaium actiylt~ nave a ,cn.an.ce Tor,sa~yage. Pts,., progressing an blsplaz~num conzalnlng ~noucz~oq cn~moznerap~ nave no chance. OT cure with any_type oT salvage regimen incl. kisp~azinum/VP16/ +/-. IfosTamioe consaining, regimen. further reports re~arding the, possiDility OT salvage. treatment in testicu~ar cancer Should De mage with respeqz ~9 ~ne pre~rea~ment cnaraq~eris~ics ana to ~ne resul~s OT ~ne prior cnemoznerapy anm par~icutarly zo the intervatTrom prior treatment to seconoary treatment. Benign thymic hyperplasia has been described in several clinical conditions, such as after cardiovascular surgery, foll~wing the stress of severe burns, after the cessation of oral corticosteroids or after chemotherapy for llmphcma's, and in endocrinological disorders like hyperthyroidism, Addison's disease, and acromegaly. With the aid of a semiquantitative score system (O,1,2 or 3) thymic size and density were evaluated in 4 patient grot!os on routine CT scans of the m~diastintm/. Grotlo 1 was ccmposed of 100 patients with testicular neoplasms, whereas grot!o 2 encluded 100 patients with other malignancies and gro~o 3 1OO patients without tumor. In group 4 52 patients suffering from M~zasthenia gravis were reviewed. CT scans were evaluated at random, considering age related changes in thymic size and density. The differences between the four groups were highly significant. The mean size in patients having a testicular neoplasm (1,54) was clearly higher as in patients belonging to group 2 (1,24) and group 3 (1,29). It was comparable to the average thymic size in Myasthenia patients (1,50). Considering the CT density, also highly significant results were obtained. Whereas the mean density in testicular tt:nor patients was I, 32 and in ~yasthenia patients 1,40, this score was 1,10 for group 2 and 1,20 for group 3 patients. Covariance analysis showed that these results are independent from sex. Further investigatiens are necessary, to explain the cause of thymic hyperplasia in testicular neoplamms, and to determine its prognostic significance. It is of great clinical importance that a thymic hyperplasia as well as prea~rtal veins or other mediastinal t~uors cam be misinterpreted as metastatic lymph nodes.
Abteilt~g diagnostische Radiologie I, M H H, K. O/tschowstrasse 8, D-3000 Hannover 61. Io this phase-ll study th?,3Td~qgzcombination Cisplatinum. ultra nigq.9ose~Etoppsioetv~Io)Z~leomyc~nwas inyestigateQ In pzs. wl~n DU/Ky o~sease, oeTlneq as TO~lOWS:ADaomlnal mass more than lu cm m, meoiastinal mass>b cm, lung metastases more than 5 and a minimum of 2 cm B each, wsceral, bone-or ZMS-metastases. Karnofsky-lndex > than 50% and acreatinine clearance > 60 ml/min was required. Dosaqe and schedule: Cisplatinum 35 mg/m 2 i.v. (2 h-infusiod) day I -5, VP16 I~0 mg/m 2 day I;5 d~v~ded in t~o daily dosaqes ~2 h-]nTusion), mleomyciq ib mg/m~ i.V~^DOIUS qay i~8,15. bycles nave oeen repeateo on aay #~ -~ accoroing ~o the Done marrow recoverx, TOt 4 cycles, burgery oT all resioual mass ~T poiseD.el was requireo after inp~ction cne T m~therap~lng.>K-ra~e i~.~..91~ aqoi~i2~L~Y~U~caJ~ m~u are zo% wlzn an overall bK/mhu-ra~e OT /U~, rK ~u%. ~b 1%, P 8%. Median duration of r'u,,i~io,, i~ 19+ (2-39+) mt~s. with no diff,erence for chemical!y or .surgically inouced CR. Median suration of PR is 8+ (2-31+) mths. With a retapse rate of 8%after a meoian ouraZion of 5 (2-i~ m~ns. and ~ne ~e~na] zoxicity after compjeze remission ~x lung, zx ileu%), o• of the pts:, ar 9 stil~ living without ~umor and /~% are living wizngu%, progression of zne aisease and are potentially cured.,jne toxicity was sexere with mainly. Doneomarrow toxicizy s namir l.Juu~ neurozoxic~zz ou%, skin toxicit2 *~%~ lung toxicit% 3mm with 3 pts. ~yin~ .of pulmonary Cibros~s after andwithout surgery, qtqzoxlcizy z*%~ sepsis 12%, reversible renal ~ox~cizy z4%, cardiac zoxicizy 8%. bonclusion: This reqimen is very active in pzs. with bulky disease OT metastasized testicular cancer. 2/3 of the w~ole pt.-population are potentially cured, in contrast to I/3 with conventional, c,hemothe,rapy regimens. Particul,arly.pts. with memium sizem oulKy aisease nave the mosz oeneT~t. Pts. with very far advanced disease still are not as good with an overall disease free rate of 57% 147 pts.~. For this subgroup still more active regimens have to be investigated, whereas for the subgroup with bulky disease in meoium range this regimen can be defined as the treatment oT cnoice, mespi%e izs toxicity. The cortical width of the right clavicle was measured in ecnventional chest X-rays, in 20 patients castrated for bilateral testicular tL~nours, and in a group of 50 heal ~ thy male subjects. All patients were aged between 20 and 45 years. The M-ray images were evaluated at random. The values for three so-called cortico-diaphyseal indiaes were calculated : 1)"combined cortical thickness" (CC~), 2)the "Barnett-Nordin index" (BNI) and 3) the "bone areas index" (IBA). In most of the 20 orchiectcmized patients a minimum of 2 images were evaluated : one at the moment of the seo0nd orchiec~, the other 0,5 to 14 years later ( mean : 6,5 years ). To raise the reliability of our meas~ts, intermediate images were evaluated, when available. In spite of a regular Testc~ter~ substituticn therapy with Testosterone-oenanthate or Testosterone-uadecancate a progressive loss of bone mineral ccntent was noted in 18/20 patients. In 9/12 patients that were orchiectomized more than 3 years ago, an osteoporosis could be diagnozed. From 8 patients ccntrolled less than 3 years only 3 had pathological indices. All but one patient were treated with usual doses of Testosterone, and Testosterone blood levels were "nozmal". In the ~ of 50 healthy patients only 2 had abnormal io~ indioes for their age, shying the reliability of the method.
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In conclusion, with this study we have detected with a simple and reliable radiological method that in patients treated for a bilateral testicular tumor by operation, in spits of regular Testosterone substitution, an early osteoporosis tin/st be feared.
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